Peptide Initiative

Injection guide · Weight Management

How to inject Liraglutide

FDA-approved once-daily GLP-1 receptor agonist (Victoza/Saxenda) that reduces HbA1c by 0.9–1.6%, promotes 5–10% body weight loss, and demonstrated a 13% reduction in major adverse cardiovascular events in the landmark LEADER trial of 9,340 patients

SubcutaneousRoute
3 recommendedSites
Once dailyFrequency

01 · Preparation

What you'll need

  • Liraglutide vial (lyophilized powder or solution)
  • Bacteriostatic water or sterile sodium chloride for reconstitution
  • Alcohol swabs for cleaning vial tops and injection sites
  • Appropriately sized syringes with fine-gauge needles (27-30 gauge)
  • Sharps disposal container

Pro tip

Prepare all supplies on a clean surface before you begin. Having everything ready makes the process smoother and more sterile.

02 · Mixing

Reconstitution steps

  1. Wash your hands thoroughly with soap and water. Gather all supplies on a clean, flat surface.
  2. Remove the plastic cap from the peptide vial and wipe the rubber stopper with an alcohol swab. Let it air dry.
  3. Draw the appropriate amount of bacteriostatic water into a sterile syringe.
  4. Insert the needle into the vial at an angle, aiming at the inside wall of the vial. Slowly push the plunger to let the water trickle down the glass wall -- do NOT squirt directly onto the powder.
  5. Once all water is added, gently swirl the vial in a slow circular motion. Never shake the vial, as this can damage the peptide bonds.
  6. Continue swirling until the powder is completely dissolved and the solution is clear. If particles remain, let the vial sit for a few minutes and swirl again.
  7. Label the vial with the date of reconstitution, the peptide name, and the concentration (e.g. 250mcg per 0.1mL).

Example calculation

Add the recommended volume of bacteriostatic water to the Liraglutide vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.

Dose calculation

Your dose of Liraglutide is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.

Pro tip

Always add the bacteriostatic water slowly, letting it run down the side of the vial. Never shake the vial -- swirl gently to avoid damaging the peptide.

03 · Location

Choosing your injection site

  • Site 01AbdomenPinch the skin 2 inches from navel. Avoid the area directly around the belly button. Rotate between left and right sides.
  • Site 02Outer ThighMiddle third of the outer thigh. Keep at least 4 inches above the knee and below the hip. Alternate legs each injection.
  • Site 03Upper ArmBack or outer area of the upper arm. This site may require assistance from another person for proper technique.

Rotate between 3 sites to prevent tissue buildup and ensure consistent absorption.

Pro tip

Rotate your injection sites with each dose to prevent lipohypertrophy (buildup of fatty tissue). Keep a simple log of where you last injected.

04 · Step by step

Injection technique

  1. Wash your hands thoroughly with soap and water before handling supplies
  2. Clean the injection site with an alcohol swab and let it air dry completely
  3. Pinch a fold of skin at the chosen injection site
  4. Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
  5. Inject the medication slowly and steadily over 5-10 seconds
  6. Release the skin fold and remove the needle, applying gentle pressure with a clean swab
  7. Rotate injection sites to prevent tissue irritation or lipodystrophy
  8. Dispose of the needle safely in a sharps container—never recap or reuse needles

Pro tip

This peptide uses subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training. Inject at a 45-90 degree angle into pinched skin. Aspirate before injecting to ensure you haven't hit a blood vessel.

05 · Timing

Your schedule

How often

Once daily

Best time

Administer Liraglutide at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.

Dose levels, food and stacking notes and a sample day are on the Liraglutide dosing protocol.

06 · Preservation

Proper storage

Before mixing

Store Liraglutide in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After mixing

Once reconstituted, Liraglutide should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Shelf life after mixing

30 days after first use whether refrigerated or at room temperature

Signs of degradation

Discard the vial immediately if you notice any of these:

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

07 · Important

Safety reminders

When to stop

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Liraglutide
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Liraglutide should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Clean technique checklist

  • Wash hands thoroughly with soap and water before handling supplies
  • Swab vial tops and injection site with alcohol and let dry
  • Never touch the needle tip or allow it to contact non-sterile surfaces
  • Use a new syringe and needle for each injection
  • Dispose of used sharps in a proper sharps container
  • Store reconstituted peptides according to the storage instructions above

Continue

This guide is for informational purposes only and is not medical advice. Always consult with a qualified healthcare provider before starting any peptide protocol. Individual responses may vary.